Position in CUE
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$1,509,325
+$1,264,447 QoQ
Shares Held
47,824
+34.8% QoQ
Ownership
0.658%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#12
of 49 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CUE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GEODE CAPITAL MANAGEMENT, LLC holds $21,877,764,044 across 520 Biotechnology names. CUE ranks #298 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,017,848 | $2,989,245,636 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,625,810 | $1,637,297,566 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,635,840 | $793,466,914 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
3,942,676 | $738,384,360 | |
| 5 | MRNA |
Moderna, Inc.
|
9,710,335 | $680,014,759 | |
| 6 | INCY |
Incyte Corp
|
4,750,735 | $538,543,319 | |
| 7 | RPRX |
Royalty Pharma plc
|
8,058,048 | $451,814,751 | |
| 8 | INSM |
INSMED Inc
|
4,220,155 | $449,952,925 |
All Filings in CUE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,509,325 | 47,824 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $244,878 | 1,064,690 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $245,003 | 803,291 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $575,752 | 800,768 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $472,060 | 692,173 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $632,132 | 693,890 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $688,095 | 631,281 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $385,181 | 508,827 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $610,644 | 492,456 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $1,584,823 | 838,531 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $2,147,072 | 813,285 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $1,753,568 | 762,421 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $2,662,474 | 729,445 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $1,616,381 | 452,768 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $900,106 | 315,827 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $665,891 | 298,606 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $742,199 | 298,072 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $2,676,216 | 548,405 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $5,897,079 | 521,404 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $8,777,142 | 602,412 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $6,015,116 | 516,319 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $5,929,797 | 486,049 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $5,387,594 | 430,663 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $5,893,685 | 391,607 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $9,246,103 | 377,238 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $4,378,849 | 308,587 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||